Literature DB >> 6372703

Toxic epidermal necrolysis. Granulocytic leukopenia as a prognostic indicator.

E D Westly, H L Wechsler.   

Abstract

Drug-induced toxic epidermal necrolysis is a disease of severe morbidity and high mortality. In the ten cases reported herein, therapeutic measures, including antibiotics, closed mechanical ventilation, maintenance of fluid and electrolyte balance, and management in special burn-care units, failed to alter a poor prognosis. The administration of corticosteroids was of no apparent benefit and may have been detrimental. Young age seemed to have a favorable influence on survival. There developed a pattern of leukopenia due to severe granulocytopenia that proved to be of prognostic importance. Persistence of the granulocytopenia portended a fatal outcome, whereas recovery of the granulocyte count to normal indicated, overall, a more favorable trend. The cause of the granulocytopenia could not be determined.

Entities:  

Mesh:

Year:  1984        PMID: 6372703     DOI: 10.1001/archderm.120.6.721

Source DB:  PubMed          Journal:  Arch Dermatol        ISSN: 0003-987X


  10 in total

1.  Toxic epidermal necrolysis: a burn-centre challenge.

Authors:  W Peters; J Zaidi; L Douglas
Journal:  CMAJ       Date:  1991-06-01       Impact factor: 8.262

2.  Fatal multisystemic toxicity associated with prophylaxis with pyrimethamine and sulfadoxine.

Authors:  R K Curley; A W Macfarlane
Journal:  Br Med J (Clin Res Ed)       Date:  1985-02-09

3.  An international comparison of case definition of severe adverse cutaneous reactions to medicines.

Authors:  R S Stern; E Albengres; J Carlson; D Chen; C Kreft; W Dai; M Joseph; H Tilson; B E Wiholm; C Kraft
Journal:  Drug Saf       Date:  1993-01       Impact factor: 5.606

4.  Phenytoin-induced Lyell's syndrome.

Authors:  Bárbara Lobão; Claúdio Martins; Manuel Sousa; Susana Marques; Ermelinda Pedroso
Journal:  BMJ Case Rep       Date:  2012-12-10

5.  Sjögren-like pluriglandular exocrine insufficiency after drug-induced toxic epidermal necrolysis.

Authors:  J Sabán; J R Pais; J L Rodríguez; D Boixeda
Journal:  Postgrad Med J       Date:  1991-02       Impact factor: 2.401

Review 6.  Clinical features and management of severe dermatological reactions to drugs.

Authors:  M C Raviglione; A Pablos-Mendez; R Battan
Journal:  Drug Saf       Date:  1990 Jan-Feb       Impact factor: 5.606

7.  The Treatment of Lyell'S Syndrome: our Experience.

Authors:  B Napoli; N D'Arpa; M Masellis
Journal:  Ann Burns Fire Disasters       Date:  2006-03-31

Review 8.  Amniotic membrane transplantation as a new therapy for the acute ocular manifestations of Stevens-Johnson syndrome and toxic epidermal necrolysis.

Authors:  Elizabeth Shay; Ahmad Kheirkhah; Lingyi Liang; Hossam Sheha; Darren G Gregory; Scheffer C G Tseng
Journal:  Surv Ophthalmol       Date:  2009-08-21       Impact factor: 6.048

9.  Bibliometric analysis of literature on toxic epidermal necrolysis and Stevens-Johnson syndrome: 1940 - 2015.

Authors:  Waleed M Sweileh
Journal:  Orphanet J Rare Dis       Date:  2017-01-18       Impact factor: 4.123

10.  A six-month prospective study to find out the treatment outcome, prognosis and offending drugs in toxic epidermal necrolysis from an urban institution in kolkata.

Authors:  Sudip Das; Aloke Kumar Roy; Indranil Biswas
Journal:  Indian J Dermatol       Date:  2013-05       Impact factor: 1.494

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.